Regional
Northwest Region Emergency Medical Services & Trauma Care Council
Northwest Region Emergency Medical Services & Trauma Care Council (WA) carries 54 drugs across 227 dose entries in its current published protocol, effective 2020-03-02.
The current listed document is more than 24 months old and may be outdated.
Drugs and doses54
Acetaminophen
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Fever | adult | 1000 mg | IV/PO/PR | not captured | standing | page 68 |
| Fever | peds | 15 mg/kg | IV/PO/PR | not captured | standing | page 68 |
| Mild to moderate pain | adult | 1000 mg | IV/PO | not captured | standing | pages 38, 151 |
| Mild to moderate pain | peds | 15 mg/kg | IV/PO | not captured | standing | pages 38, 151 |
| Sepsis | adult | 1000 mg | IV | not captured | standing | page 17 |
| Sepsis | peds | 15 mg/kg | IV | not captured | standing | page 17 |
Activated Charcoal
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Other | adult | 50 g | PO | not captured | standing | page 152 |
| Other | adult | 50 g | PO | not captured | standing | page 152 |
| Other | peds | 1 g/kg | PO | not captured | standing | page 152 |
| Other | peds | 1 g/kg | PO | not captured | standing | page 152 |
Adenosine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| SVT | adult | 6 mg | IV/IO | not captured | standing | pages 21, 152 |
| SVT | peds | 0.1 mg/kg | IV/IO | not captured | standing | pages 21, 152 |
| Narrow-complex tachycardia | adult | 6 mg | IV/IO | not captured | standing | pages 21, 152 |
| Narrow-complex tachycardia | peds | 0.1 mg/kg | IV/IO | not captured | standing | pages 21, 152 |
| Wide-complex tachycardia | adult | 6 mg | IV/IO | not captured | standing | pages 22, 152 |
| Wide-complex tachycardia | peds | 0.1 mg/kg | IV/IO | not captured | standing | pages 22, 152 |
Albuterol
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Anaphylaxis | adult | 2.5 mg | not captured | not captured | standing | page 61 |
| Anaphylaxis | peds | 2.5 mg | not captured | not captured | standing | page 61 |
| Asthma / bronchospasm | adult | 2.5 mg | not captured | not captured | standing | pages 29, 153 |
| Asthma / bronchospasm | adult | 2.5 mg | not captured | not captured | standing | page 153 |
| Asthma / bronchospasm | peds | 2.5–5 mg | not captured | not captured | standing | pages 29, 153 |
| Asthma / bronchospasm | peds | 2.5–5 mg | not captured | not captured | standing | page 153 |
| Crush injury | adult | 5 mg | not captured | not captured | standing | pages 49, 66 |
| Crush injury | peds | 5 mg | not captured | not captured | standing | pages 49, 66 |
| Hyperkalemia | adult | 10 mg | not captured | not captured | standing | page 25 |
Amiodarone
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Cardiac arrest | adult | 300 mg | IV/IO | not captured | standing | page 154 |
| Cardiac arrest | peds | 5 mg/kg | IV/IO | not captured | standing | page 154 |
| Other | adult | 300 mg | IV/IO | not captured | standing | pages 23, 58, 154 |
| Other | peds | 5 mg/kg | IV/IO | not captured | standing | pages 23, 58, 154 |
| Narrow-complex tachycardia | adult | 150 mg | IV/IO | not captured | standing | pages 21, 154 |
| Narrow-complex tachycardia | peds | 5 mg/kg | IV/IO | not captured | standing | pages 21, 154 |
| Wide-complex tachycardia | adult | 150 mg | IV/IO | not captured | standing | pages 22, 57, 154 |
| Wide-complex tachycardia | peds | 5 mg/kg | IV/IO | not captured | standing | pages 22, 57, 154 |
| VF / pulseless VT | adult | 300 mg | IV/IO | not captured | standing | pages 23, 58, 154 |
| VF / pulseless VT | peds | 5 mg/kg | IV/IO | not captured | standing | pages 23, 58, 154 |
Aspirin
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| ACS / chest pain | adult | 325 mg | PO | not captured | standing | page 26 |
| ACS / chest pain | adult | 325 mg | PO | not captured | standing | page 26 |
Atropine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Bradycardia | adult | 0.5–1 mg | IV | not captured | standing | pages 20, 155 |
| Bradycardia | peds | 0.02 mg/kg | IV | not captured | standing | pages 20, 155 |
| Organophosphate poisoning | adult | 2 mg | IV/IO | not captured | standing | pages 37, 66, 155 |
| Organophosphate poisoning | peds | 0.08 mg/kg | IV/IO | not captured | standing | pages 37, 66, 155 |
| Other | adult | 2–5 drop | IV | not captured | standing | pages 16, 155 |
| Other | peds | 0.02 mg/kg | IV/IO | not captured | standing | pages 53, 155 |
| RSI induction | peds | 0.02 mg/kg | IV/IO | not captured | standing | pages 53, 155 |
Bumetanide
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| CHF / pulmonary edema | adult | 0.5–2 mg | IV/IO | not captured | standing | page 156 |
Calcium Chloride
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Beta-blocker / calcium-channel-blocker overdose | adult | 1–2 g | IV/IO | not captured | standing | page 37 |
| Crush injury | adult | 1 g | IV/IO | not captured | standing | page 49 |
| Hyperkalemia | adult | 1000 mg | IV/IO | not captured | standing | page 25 |
| Hyperkalemia | peds | 10 mg/kg | IV/IO | not captured | standing | page 25 |
Clopidogrel Bisulfate
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| STEMI | adult | 300 mg | PO | not captured | standing | page 157 |
Dexamethasone
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Anaphylaxis | adult | 0.6 mg/kg | IV/IO/IM/PO | not captured | standing | page 61 |
| Anaphylaxis | peds | 0.6 mg/kg | IV/IO/IM/PO | not captured | standing | page 61 |
| Asthma / bronchospasm | adult | 0.6 mg/kg | IV/IO/IM/PO | not captured | standing | page 29 |
| Asthma / bronchospasm | peds | 0.6 mg/kg | IV/IO/IM/PO | not captured | standing | page 29 |
| Croup | adult | 0.6 mg/kg | IV/IO/IM/PO | not captured | standing | page 63 |
| Croup | peds | 0.6 mg/kg | IV/IO/IM/PO | not captured | standing | page 63 |
| Other | adult | 0.6 mg/kg | IV/IO/IM/PO | not captured | standing | page 63 |
| Other | peds | 0.6 mg/kg | IV/IO/IM/PO | not captured | standing | page 63 |
Dextrose
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Hypoglycemia | adult | 12.5–25 g | IV/IO | not captured | standing | pages 34, 158 |
| Hypoglycemia | peds | 0.5 g/kg | IV/IO | not captured | standing | pages 34, 158 |
Diazepam
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| ACS / chest pain | adult | 2–5 mg | IV/IM/IN | not captured | standing | page 26 |
| Agitation | adult | 2–5 mg | IV/IO/IM/IN | not captured | standing | pages 26, 38 |
| Eclampsia / pre-eclampsia | adult | 10 mg | PR | not captured | standing | page 159 |
| Eclampsia / pre-eclampsia | adult | 2–5 mg | IV | not captured | standing | page 159 |
| Hyperactive delirium | adult | 2–5 mg | IV/IO/IM | not captured | standing | page 39 |
| Hyperactive delirium | peds | 2–10 mg | IV/IO/IM | not captured | standing | page 39 |
| Other | adult | 2–5 mg | IV/IO | not captured | standing | page 159 |
| Other | adult | 2–5 mg | IV/IO/IM/IN | not captured | standing | page 37 |
| Other | adult | 2–5 mg | IV/IM/IN | not captured | standing | page 16 |
| Other | peds | 0.1 mg/kg | IV/IO | not captured | standing | page 159 |
| Seizure | adult | 10 mg | PR | not captured | standing | page 159 |
| Seizure | adult | 2–5 mg | IM | not captured | standing | page 159 |
| Seizure | adult | 5 mg | IV/IO | not captured | standing | page 159 |
| Seizure | peds | 0.1 mg/kg | IV/IO | not captured | standing | page 159 |
| Seizure | peds | 0.5 mg/kg | PR | not captured | standing | page 159 |
Diltiazem
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Narrow-complex tachycardia | adult | 10–25 mg | IV/IO | not captured | standing | page 21 |
Diphenhydramine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Allergic reaction | adult | 25–50 mg | PO | not captured | standing | pages 33, 160 |
| Allergic reaction | adult | 25–50 mg | IV/IM/PO | not captured | standing | pages 33, 160 |
| Allergic reaction | peds | 1 mg/kg | PO | not captured | standing | pages 33, 160 |
| Allergic reaction | peds | 1 mg/kg | IV/IM/PO | not captured | standing | pages 33, 160 |
| Nausea / vomiting | adult | 25–50 mg | PO | not captured | standing | pages 32, 36, 160 |
| Nausea / vomiting | peds | 25–50 mg | IV/IM/PO | not captured | standing | page 36 |
Epinephrine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Anaphylaxis | adult | 0.1–0.3 mg | IM | not captured | standing | pages 33, 61, 161 |
| Anaphylaxis | peds | 0.01 mg/kg | IM | not captured | standing | pages 33, 61, 161 |
| Asthma / bronchospasm | adult | 0.1–0.3 mg | IM | not captured | standing | pages 29, 161 |
| Asthma / bronchospasm | adult | 0.3 mL | not captured | not captured | standing | pages 29, 161 |
| Bradycardia | adult | 2–10 mcg | IV/IO | not captured | standing | pages 20, 55, 161 |
| Bradycardia | peds | 0.01 mg/kg | IV/IO | not captured | standing | pages 20, 55, 161 |
| Cardiac arrest | adult | 1 mg | IV/IO | not captured | standing | pages 23, 24, 58, 59, 161 |
| Cardiac arrest | peds | 0.01 mg/kg | IV/IO | not captured | standing | pages 23, 24, 58, 59, 161 |
Etomidate
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Other | adult | 0.1 mg/kg | IV/IO | not captured | standing | pages 38, 162 |
| RSI induction | adult | 0.1–0.3 mg/kg | IV | not captured | standing | pages 53, 162 |
| RSI induction | peds | 0.1–0.3 mg/kg | IV | not captured | standing | pages 53, 162 |
Famotidine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Allergic reaction | adult | 20 mg | IV/IO | not captured | standing | pages 33, 61, 163 |
| Allergic reaction | peds | 0.25 mg/kg | IV/IO | not captured | standing | pages 33, 61, 163 |
Fentanyl
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| ACS / chest pain | adult | 25 mcg | IV | not captured | standing | pages 26, 163 |
| Other | adult | 25 mcg | not captured | not captured | standing | pages 16, 163 |
| Other | peds | 2 mcg/kg | IV | not captured | standing | pages 53, 163 |
| Mild to moderate pain | adult | 1 mcg/kg | IV/IO/IM/IN | not captured | standing | pages 38, 67, 163 |
| Mild to moderate pain | peds | 1 mcg/kg | IV/IO/IM/IN | not captured | standing | pages 38, 67, 163 |
Furosemide
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| CHF / pulmonary edema | adult | 40–80 mg | IV | not captured | standing | pages 30, 164 |
| Hyperkalemia | adult | 40 mg | IV | not captured | standing | pages 25, 164 |
| Hyperkalemia | peds | 40 mg | IV | not captured | standing | pages 25, 164 |
Glucagon
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Beta-blocker / calcium-channel-blocker overdose | adult | 3–5 mg | IV/IM/IN | not captured | standing | pages 37, 164 |
| Beta-blocker / calcium-channel-blocker overdose | adult | 3–5 mg | IV/IM/IN | not captured | standing | pages 37, 164 |
| Hypoglycemia | adult | 1 mg | IM/IN | not captured | standing | pages 34, 70, 164 |
| Hypoglycemia | peds | 0.1 mg/kg | IM/IN | not captured | standing | pages 34, 70, 164 |
| Other | peds | 0.1 mg/kg | IV/IO | not captured | standing | pages 66, 164 |
Heparin Sodium
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| STEMI | adult | 60 unit/kg (max 4000 unit) | IV | not captured | standing | pages 26, 165 |
Hydromorphone
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Mild to moderate pain | adult | 0.5 mg | IV | not captured | standing | pages 26, 166 |
| Mild to moderate pain | adult | 1–2 mg | IM | not captured | standing | page 166 |
| Mild to moderate pain | peds | 0.015 mg/kg | IV | not captured | standing | pages 26, 166 |
| Mild to moderate pain | peds | 0.015 mg/kg | IM | not captured | standing | page 166 |
Ipratropium
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Allergic reaction | adult | 0.5 mg | not captured | not captured | standing | page 33 |
| Asthma / bronchospasm | adult | 0.5 mg | not captured | not captured | standing | pages 29, 63, 167 |
| Asthma / bronchospasm | peds | 0.5 mg | not captured | not captured | standing | pages 29, 63, 167 |
Ketamine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Hyperactive delirium | adult | 5–10 mg/kg | IM | not captured | standing | pages 39, 167 |
| Hyperactive delirium | peds | 5–10 mg/kg | IM | not captured | standing | pages 39, 167 |
| Other | adult | 0.5–1 mg/kg | IV/IO | not captured | standing | pages 37, 66 |
| Other | peds | 0.5–1 mg/kg | IV/IO | not captured | standing | pages 37, 66 |
| Mild to moderate pain | adult | 0.25 mg/kg | IV/IO | not captured | standing | page 67 |
| Mild to moderate pain | adult | 0.5 mg/kg | IM | not captured | standing | pages 38, 67 |
| Procedural sedation | adult | 0.5–2 mg/kg | IV/IO | not captured | standing | pages 38, 167 |
| Procedural sedation | peds | 0.5–2 mg/kg | IV/IO | not captured | standing | pages 38, 167 |
| RSI induction | adult | 1–2 mg/kg | IV | not captured | standing | pages 53, 167 |
| RSI induction | peds | 4–5 mg | IM | not captured | standing | pages 53, 167 |
Ketorolac
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Mild to moderate pain | adult | 15 mg | IV | not captured | standing | pages 17, 36, 169 |
| Mild to moderate pain | adult | 30 mg | IM | not captured | standing | pages 32, 169 |
| Mild to moderate pain | peds | 0.5 mg/kg | IV | not captured | standing | pages 17, 36, 169 |
| Mild to moderate pain | peds | 1 mg/kg | IM | not captured | standing | pages 32, 169 |
Labetalol
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| ACS / chest pain | adult | 10–20 mg | IV | not captured | standing | page 26 |
| Other | adult | 10–20 mg | IV | not captured | standing | page 170 |
Lidocaine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Other | adult | 0.5–1 mg/kg | IV/IO | not captured | standing | page 171 |
| Wide-complex tachycardia | adult | 1–1.5 mg/kg | IV/IO | not captured | standing | page 22 |
| Wide-complex tachycardia | peds | 1–1.5 mg/kg | IV/IO | not captured | standing | page 22 |
| VF / pulseless VT | adult | 1–1.5 mg/kg | IV/IO | not captured | standing | page 23 |
| VF / pulseless VT | peds | 1–1.5 mg/kg | IV/IO | not captured | standing | page 23 |
Lorazepam
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| ACS / chest pain | adult | 0.5–4 mg | IV/IM/IN | not captured | standing | page 26 |
| Hyperactive delirium | adult | 0.5–2 mg | IV/IO/IM/IN | not captured | standing | page 38 |
| Hyperactive delirium | peds | 0.5–2 mg | IV/IO/IM/IN | not captured | standing | page 38 |
| Other | adult | 0.5–2 mg | IV/IO/IM/IN | not captured | standing | page 39 |
| Other | adult | 0.5–4 mg | IV/IM/IN | not captured | standing | page 16 |
| Other | peds | 0.5–4 mg | IV/IO/IM/IN | not captured | standing | page 39 |
| Seizure | adult | 1–2 mg | IV/IO/IM/IN | not captured | standing | page 70 |
| Seizure | peds | 0.1 mg/kg | IV/IO/IM/IN | not captured | standing | page 70 |
Magnesium Sulfate
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Asthma / bronchospasm | adult | 2 g | IV | not captured | standing | pages 29, 63 |
| Crush injury | adult | 1 mEq/kg | IV | not captured | standing | page 49 |
| Crush injury | peds | 1 mEq/kg | IV | not captured | standing | page 49 |
| Eclampsia / pre-eclampsia | adult | 4 g | IV | not captured | standing | page 42 |
| Wide-complex tachycardia | adult | 2 g | IV | not captured | standing | page 22 |
| Wide-complex tachycardia | peds | 50 mg/kg | IV | not captured | standing | page 22 |
| VF / pulseless VT | adult | 2 g | IV | not captured | standing | page 23 |
| VF / pulseless VT | peds | 50 mg/kg | IV | not captured | standing | page 23 |
Methylprednisolone
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Allergic reaction | adult | 125 mg | IV/IO/IM | not captured | standing | page 33 |
| Allergic reaction | peds | 2 mg/kg | IV/IO/IM | not captured | standing | page 33 |
| Anaphylaxis | adult | 125 mg | IV/IO/IM | not captured | standing | page 61 |
| Anaphylaxis | peds | 2 mg/kg | IV/IO/IM | not captured | standing | page 61 |
| Asthma / bronchospasm | adult | 125 mg | IV/IO/IM | not captured | standing | pages 29, 63 |
| Asthma / bronchospasm | peds | 2 mg/kg | IV/IO/IM | not captured | standing | pages 29, 63 |
Metoprolol
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| ACS / chest pain | adult | 2.5–5 mg | IV | not captured | standing | page 26 |
| Narrow-complex tachycardia | adult | 2.5–5 mg | IV | not captured | standing | page 21 |
Midazolam
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| ACS / chest pain | adult | 2.5–5 mg | IV/IM/IN | not captured | standing | page 26 |
| Hyperactive delirium | adult | 2.5–5 mg | IV/IO/IM/IN | not captured | standing | pages 38, 39 |
| Hyperactive delirium | peds | 2.5–10 mg | IV/IO/IM/IN | not captured | standing | pages 38, 39 |
| Other | adult | 2.5–5 mg | IV/IM/IN | not captured | standing | page 16 |
| Procedural sedation | adult | 2–2.5 mg | IV/IO/IM/IN | not captured | standing | page 16 |
| RSI induction | adult | 0.1 mg/kg | IV/IO | not captured | standing | pages 93, 94 |
| RSI induction | peds | 0.1 mg/kg | IV/IO | not captured | standing | pages 93, 94 |
| Seizure | adult | 2.5–5 mg | IV/IM/IN | not captured | standing | page 40 |
| Seizure | peds | 5–10 mg | IV/IM/IN | not captured | standing | page 40 |
Morphine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Mild to moderate pain | adult | 2 mg | IV | not captured | standing | pages 26, 38, 177 |
| Mild to moderate pain | adult | 2 mg | IM | not captured | standing | pages 26, 38, 177 |
| Mild to moderate pain | peds | 0.1 mg/kg | IV | not captured | standing | pages 26, 38, 177 |
| Mild to moderate pain | peds | 0.1 mg/kg | IM | not captured | standing | pages 26, 38, 177 |
Naloxone
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Opioid overdose | adult | 0.4–4 mg | IN | not captured | standing | pages 37, 65, 177 |
| Opioid overdose | adult | 0.4–4 mg | IV/IO/IM | not captured | standing | pages 37, 65, 177 |
| Opioid overdose | peds | 0.1 mg/kg | IN | not captured | standing | pages 37, 65, 177 |
| Opioid overdose | peds | 0.1 mg/kg | IV/IO/IM | not captured | standing | pages 37, 65, 177 |
Nitroglycerin
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| ACS / chest pain | adult | 0.4 mg | SL | not captured | standing | pages 26, 30, 178 |
| ACS / chest pain | adult | 1 inch | TOP | not captured | standing | pages 26, 30, 178 |
Norepinephrine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Hypotension / shock | adult | 2–20 mcg | IV/IO | not captured | standing | pages 17, 19, 31, 180 |
| Hypotension / shock | adult | 2–20 mcg | IV/IO | not captured | standing | page 19 |
| Other | adult | 2–20 mcg | IV/IO | not captured | standing | page 31 |
| Sepsis | adult | 2–20 mcg | IV/IO | not captured | standing | page 17 |
Ondansetron
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Nausea / vomiting | adult | 4 mg | SL | not captured | standing | pages 32, 36, 181 |
| Nausea / vomiting | adult | 4–8 mg | IV/IM | not captured | standing | pages 32, 36, 181 |
| Nausea / vomiting | peds | 0.15 mg/kg | SL | not captured | standing | pages 32, 36, 181 |
| Nausea / vomiting | peds | 0.15 mg/kg | IV/IM | not captured | standing | pages 32, 36, 181 |
Oral Glucose
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Hypoglycemia | adult | One tube | PO | not captured | standing | pages 34, 37, 65, 165 |
| Hypoglycemia | adult | One tube | PO | not captured | standing | page 165 |
| Hypoglycemia | peds | One tube | PO | not captured | standing | pages 34, 37, 65, 165 |
| Hypoglycemia | peds | One tube | PO | not captured | standing | page 165 |
| Other | peds | One tube | PO | not captured | standing | page 64 |
Oxymetazoline
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Other | adult | 2–3 puff | IN | not captured | standing | page 182 |
| RSI induction | adult | 2–3 puff | IN | not captured | standing | pages 92, 182 |
Oxytocin
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Obstetric hemorrhage | adult | 10 unit | IM | not captured | standing | page 43 |
| Obstetric hemorrhage | adult | 20 unit | IV | not captured | standing | page 43 |
Prednisone
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Asthma / bronchospasm | adult | 60 mg | PO | not captured | standing | pages 29, 183 |
| Asthma / bronchospasm | peds | 1–2 mg/kg | PO | not captured | standing | pages 29, 183 |
Procainamide
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Other | adult | 20 mg | IV | not captured | standing | page 21 |
| Other | adult | 20 mg | IV | not captured | standing | page 22 |
| Other | adult | 4 mg/kg | IV | not captured | standing | pages 56, 57 |
| Other | peds | 4 mg/kg | IV | not captured | standing | pages 56, 57 |
Promethazine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Nausea / vomiting | adult | 6.25–12.5 mg | IV/IM | not captured | standing | pages 32, 36, 50, 61, 184 |
| Nausea / vomiting | peds | 6.25–12.5 mg | IV/IM | not captured | standing | pages 32, 36, 50, 61, 184 |
Propofol
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Hyperactive delirium | adult | 20–50 mg | IV | not captured | standing | page 185 |
Rocuronium
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| RSI induction | adult | 0.6–1.2 mg/kg | IV | not captured | standing | pages 53, 93, 94, 186 |
| RSI induction | peds | 0.6–1.2 mg/kg | IV | not captured | standing | pages 53, 93, 94, 186 |
Sodium Bicarbonate
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Cardiac arrest | adult | 1 mEq/kg | IV/IO | not captured | standing | pages 23, 24, 25, 37, 58, 59 |
| Cardiac arrest | peds | 1 mEq/kg | IV/IO | not captured | standing | pages 23, 24, 25, 37, 58, 59 |
| Hyperkalemia | adult | 1 mEq/kg | IV/IO | not captured | standing | pages 25, 49 |
| Hyperkalemia | peds | 1 mEq/kg | IV/IO | not captured | standing | pages 25, 49 |
| Other | adult | 1.5 mEq/kg | IV/IO | not captured | standing | pages 37, 66 |
| Other | adult | 50 mEq | IV/IO | not captured | standing | pages 34, 35 |
| Other | peds | 1 mEq/kg | IV/IO | not captured | standing | pages 37, 66 |
| Other | peds | 50 mEq | IV/IO | not captured | standing | pages 34, 35 |
Succinylcholine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Other | peds | 2 mg/kg | IV | not captured | standing | pages 53, 187 |
| RSI induction | adult | 1.5 mg/kg | IV | not captured | standing | pages 93, 187 |
| RSI induction | peds | 2 mg/kg | IV | not captured | standing | pages 93, 187 |
Tenecteplase
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| STEMI | adult | 30 mg | IV | not captured | standing | page 187 |
Thiamine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Other | adult | 100 mg | IV/IM | not captured | standing | pages 34, 188 |
Ticagrelor
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| STEMI | adult | 180 mg | PO | not captured | standing | page 188 |
Tranexamic Acid
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Trauma / hemorrhage | adult | 1 g | IV | not captured | standing | pages 45, 189 |
| Trauma / hemorrhage | peds | 15 mg/kg | IV | not captured | standing | pages 45, 189 |
Vecuronium
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| RSI induction | adult | 0.1 mg/kg | IV | not captured | standing | pages 94, 191 |
| RSI induction | peds | 0.1 mg/kg | IV | not captured | standing | pages 94, 191 |
Verapamil
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Narrow-complex tachycardia | adult | 5 mg | IV/IO | not captured | standing | pages 21, 191 |